Telomerase and cancer therapeutics

CB Harley - Nature Reviews Cancer, 2008 - nature.com
Telomerase is an attractive cancer target as it appears to be required in essentially all
tumours for immortalization of a subset of cells, including cancer stem cells. Moreover …

Therapeutic targeting of telomerase

K Jäger, M Walter - Genes, 2016 - mdpi.com
Telomere length and cell function can be preserved by the human reverse transcriptase
telomerase (hTERT), which synthesizes the new telomeric DNA from a RNA template, but is …

Targeting telomerase for cancer therapeutics

JW Shay, WN Keith - British journal of cancer, 2008 - nature.com
One of the hallmarks of advanced malignancies is continuous cell growth and this almost
universally correlates with the reactivation of telomerase. Although there is still much we do …

Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity

CJ Cairney, WN Keith - Biochimie, 2008 - Elsevier
Telomerase activity is dependent on the expression of 2 main core component genes,
hTERT, which encodes the catalytic component and hTR (also called TERC), which …

Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management

L Cheng, S Zhang, M Wang, A Lopez-Beltran - Human Pathology, 2023 - Elsevier
The telomerase reverse transcriptase (TERT) promoter mutations are associated with
increased TERT mRNA and TERT protein levels, telomerase activity, and shorter but stable …

Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia

G Roos, A Kröber, P Grabowski… - Blood, The Journal …, 2008 - ashpublications.org
Telomere length is associated with mutation status of the immunoglobulin heavy chain
variable (IGHV) gene and clinical course in B-cell chronic lymphocytic leukemia (B-CLL). In …

[HTML][HTML] Therapeutic targeting of replicative immortality

P Yaswen, KL MacKenzie, WN Keith, P Hentosh… - Seminars in cancer …, 2015 - Elsevier
One of the hallmarks of malignant cell populations is the ability to undergo continuous
proliferation. This property allows clonal lineages to acquire sequential aberrations that can …

Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer

CQ Zhu, JC Cutz, N Liu, D Lau, FA Shepherd… - British journal of …, 2006 - nature.com
Telomerase reactivation is a hallmark of human carcinogenesis. Increased telomerase
activity may result from gene amplification and/or overexpression. This study evaluates the …

Anticancer drug design using scaffolds of β-lactams, sulfonamides, quinoline, quinoxaline and natural products. Drugs advances in clinical trials

I Balderas-Renteria… - Current medicinal …, 2012 - ingentaconnect.com
Eleven years after the start of a new millennium characterized by amazing scientific
development, the cure for cancer remains a major challenge for humanity. In this regard …

Telomeres and telomerase: Pharmacological targets for new anticancer strategies?

F Pendino, I Tarkanyi, C Dudognon… - Current Cancer Drug …, 2006 - ingentaconnect.com
Telomeres are located at the ends of eukaryotic chromosomes. Human telomerase, a
cellular reverse transcriptase, is a ribonucleoprotein enzyme that catalyzes the synthesis …